Table 4.
NO.
| Group | n | Plasma NO (μmol l−1) | Myocardium NO (pmol g−1) | ||
|---|---|---|---|---|---|
| Before | After | Before | After | ||
| Control | 8 | 22.06 ± 4.61 | 21.58 ± 4.75 | 1.21 ± 0.20 | 1.19 ± 0.19 |
| Captopril | 9 | 21.76 ± 5.12 | 36.07 ± 5.28∗∗,§ | 1.13 ± 0.24 | 1.83 ± 0.20∗,Δ |
| SHR-350 Hz | 9 | 23.44 ± 5.33 | 32.65 ± 6.43∗∗,§ | 1.18 ± 0.17 | 1.68 ± 0.15∗,Δ |
| SHR-WAB | 8 | 21.39 ± 4.86 | 29.53 ± 5.20∗,§ | 1.26 ± 0.32 | 1.56 ± 0.14 |
*P < .05 versus control; **P < .01 versus control. § P < .01 versus baseline of the same group. Δ P < .05 versus baseline of the same group.